Nu Skin (NYSE:NUS) now expects Q2 EPS in the range of of $0.82- $0.84 vs. a consensus of $0.93; Revenue in the range of $622M – $623M vs. a consensus of $671.81M.
The company’s revised revenue outlook for 2019 is $2.48 to $2.52B (cons. $2.77B) and EPS of $3.20 to $3.35 (cons. $3.94).
“We are adjusting our guidance for the year primarily due to a reduced revenue outlook in Mainland China following the government’s 100-day campaign to review and inspect the health products and direct selling industries,” said Ritch Wood, chief executive officer.
Shares -19% AH.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.